Buccal Midazolam

New guidelines for Buccal Midazolam


The Epilepsy Nurses Association (ESNA) has launched new best practice training guidelines for the administration of Buccal Midazolam for epilepsy patients.

The usage of Buccal Midazolam is often when a person’s seizure lasts longer than normal. Also, where it is unlikely the seizure will terminate without medical intervention. Therefore there is a risk of status epilepticus. Status epilepticus is when there are a cluster of seizures and can cause serious brain damage and sometimes death.

The guidelines will support best practice when training carers who are administering or overseeing the use of Buccal Midazolam for the treatment of prolonged and / or clusters of epileptic seizures. The guidelines replace the former Joint Epilepsy Council (JEC) guidelines on the use of Buccal Midazolam.

The International League Against Epilepsy (ILAE) and the Royal College of Psychiatrists collaborated to produce ESNA’s latest guidelines. They outline important safety standards for first aid intervention. This while demonstrating the need for awareness, training and consistent review of epilepsy knowledge and protocol.

The ESNA best practice guidelines for training carers in the administration of Buccal Midazolam can be accessed via the ESNA website and the Virtual College website.

For more information about the new guidelines, please contact ESNAepilepsynursesassociation@outlook.com